Literature DB >> 13202487

Megaloblastic anaemia due to phenytoin sodium.

C F HAWKINS, M J MEYNELL.   

Abstract

Entities:  

Keywords:  ANEMIA, HYPERCHROMIC/etiology and pathogenesis; EPILEPSY/therapy; HYDANTOINS/injurious effects

Mesh:

Substances:

Year:  1954        PMID: 13202487     DOI: 10.1016/s0140-6736(54)90499-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  Megaloblastic anaemia following anticonvulsants.

Authors:  N BERLYNE; M LEVENE; A McGLASHAN
Journal:  Br Med J       Date:  1955-05-21

2.  Megaloblastic anaemia due to phenytoin sodium.

Authors:  G M RYAN; J W FORSHAW
Journal:  Br Med J       Date:  1955-07-23

3.  Folic acid deficiency and the megaloblastic anaemias.

Authors:  I CHANARIN; D L MOLLIN; B B ANDERSON
Journal:  Proc R Soc Med       Date:  1958-09

4.  Megaloblastic anaemia due to phenobarbitone; the convulsant action of therapeutic doses of folic acid.

Authors:  I CHANARIN; J LAIDLAW; L W LOUGHRIDGE; D L MOLLIN
Journal:  Br Med J       Date:  1960-04-09

5.  Megaloblastic anaemia induced by phenylbutazone.

Authors:  H N ROBSON; J R LAWRENCE
Journal:  Br Med J       Date:  1959-09-19

6.  Megaloblastic anaemia due to anticonvulsant therapy: report of a case responding to vitamin B12.

Authors:  P C MACINTOSH; J L HUTCHISON
Journal:  Can Med Assoc J       Date:  1960-02-13       Impact factor: 8.262

7.  Megaloblastic anaemia occurring during primidone therapy.

Authors:  R H GIRDWOOD; J A LENMAN
Journal:  Br Med J       Date:  1956-01-21

8.  Drugs used in the management of epilepsy.

Authors:  H GARLAND
Journal:  Proc R Soc Med       Date:  1957-08

9.  Folic-acid studies in megaloblastic anaemia due to primidone.

Authors:  I CHANARIN; P C ELMES; D L MOLLIN
Journal:  Br Med J       Date:  1958-07-12

10.  Cholestyramine and medium-chain triglyceride in prolonged management of patients subjected to ileal resection or bypass.

Authors:  C N Williams; R C Dickson
Journal:  Can Med Assoc J       Date:  1972-10-07       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.